Can Fam Physician. 1988 Apr;34:819-22.
Post-marketing surveillance is a mechanism to identify and quantify harmful, as well as beneficial, effects of drugs used under conditions different from those in which they were tested. The College of Family Physicians of Canada collaborated with the authors in a pilot, office-based, post-marketing, surveillance study. Target medications were selected from all prescriptions, written or authorized by participating physicians. The participants collected the prescriptions by using duplicate prescription pads. Follow-up data was collected from the patients by means of a self-administered questionnaire and from the physicians by means of a medical-chart review. This method of research allows the identification of a cohort of drug users in a systematic, non-biased fashion.
上市后监测是一种机制，用于识别和量化药物在与测试条件不同的情况下使用所产生的有害和有益影响。加拿大家庭医生学院与作者合作开展了一项试点、基于诊所的上市后监测研究。目标药物是从所有由参与医生开出或授权的处方中选择的。参与者使用重复的处方垫收集处方。通过自填式问卷从患者收集随访数据，通过病历回顾从医生收集随访数据。这种研究方法可以系统、无偏地确定药物使用者队列。
